Effects of Chenodeoxycholate and a Bile Acid Sequestrant, Colesevelam, on Intestinal Transit and Bowel Function
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Background & Aims Di-α hydroxy bile salt, sodium chenodeoxycholate (CDC), and bile acid (BA) binding have unclear effects on colonic transit in health and disease. Methods We performed 2 randomized, double-blind, placebo-controlled studies. In healthy volunteers (20/group), we evaluated effects of oral placebo, 500 mg, or 1000 mg of CDC (delayed-release, each given for 4 days) on gastrointestinal and colonic transit. A second trial compared the effects of colesevelam (1.875g, twice daily) vs placebo in 24 patients (12/group) with diarrhea-predominant irritable bowel syndrome (IBS-D) on transit, daily bowel frequency and consistency, and colonic mucosal permeability. Serum fasting 7αC4 was measured to screen for BA malabsorption. Effects of treatments on transit were compared using analysis of covariance with body mass index (BMI) and 7αC4 as covariates. Results In healthy volunteers, CDC significantly accelerated colonic transit (at 24h and 48h, p=0.01 and p<0.0001, respectively), increased stool frequency, ease of passage (both p<0.001), and evacuation (p=0.02), and decreased stool consistency (p<0.001). Four of the 24 IBS-D patients had increased serum 7αC4. In IBS-D, colesevelam modestly affected overall colonic transit (24h, p=0.22). Emptying of the ascending colon took an average 4 hours longer in patients given colesevelam compared to placebo; treatment effect was associated with baseline serum 7αC4 (p=0.0025). Colesevelam was associated with greater ease of stool passage (p=0.048) and somewhat firmer stool consistency (p=0.12). No effects on mucosal permeability or safety were identified. Conclusions Sodium chenodeoxycholate in health and colesevelam in IBS-D patients have opposite effects on colonic transit and fecal parameters.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139 · cited 1×
“questionnaires: Hospital Anxiety and Depression (HAD) Scale [16], SCL-90 (somatization) [17], and bowel function by validated daily diaries including Bristol Stool Form Scale (BSFS) scores [18].”
MethodSCL-90: an outpatient psychiatric rating scale--preliminary report.
Derogatis, L. R., Lipman, R. S., & Covi, L. (1973) · PubMed · Cited by 4,633
Stool form scale as a useful guide to intestinal transit time
Lewis, S. J., & Heaton, K. W. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709011203 · Cited by 3,244 · cited 3×
“In these studies, we examined stool diaries [18], gastrointestinal transit [19–23], serum 7α-C4 [22], serum FGF-19, and colonic mucosal permeability [24].”
MethodThe Continuing Importance of Bile Acids in Liver and Intestinal Disease
Hofmann, A. F. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.22.2647 · Cited by 982 · cited 1×
“Bile acids have a variety of physiologic functions, and are actively reabsorbed (up to 95%) in the terminal ileum [1].”
BackgroundColonic Secretion of Water and Electrolytes Induced by Bile Acids: Perfusion Studies in Man
Mekhjian, H. S., Phillips, S. F., & Hofmann, A. F. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106644 · Cited by 584 · cited 1×
“Conjugated and non-conjugated bile acids induce secretion in the human colon [3,4] by one or more mechanisms: activating intracellular secretory mechanisms (e.”
BackgroundWEDLAKE, L., A’HERN, R., RUSSELL, D., THOMAS, K., WALTERS, J. R. F., & ANDREYEV, H. J. N. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04081.x · Cited by 435
A New Mechanism for Bile Acid Diarrhea: Defective Feedback Inhibition of Bile Acid Biosynthesis
Walters, J. R. F., Tasleem, A. M., Omer, O. S., Brydon, W. G., Dew, T., & le Roux, C. W. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.04.024 · Cited by 318 · cited 1×
“recently reported reduced plasma levels of fibroblast growth factor (FGF)-19 which is produced by enterocytes [14] in the ileum in response to bile acid absorption and regulates hepatic bile acid synthesis.”
BackgroundDavidson, M. H., Dillon, M. A., Gordon, B., Jones, P., Samuels, J., Weiss, S., Isaacsohn, J., Toth, P., & Burke, S. K. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.16.1893 · Cited by 307
CHADWICK, V. S., Gaginella, T. S., Carlson, G. L., Debongnie, J. C., Phillips, S. F., & Hofmann, A. F. (1979) · PubMed · Cited by 271
The proximal colonic motor response to rectal mechanical and chemical stimulation
Bampton, P. A., Dinning, P. G., Kennedy, M. L., Lubowski, D. Z., & Cook, I. J. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00194.2001 · Cited by 215 · cited 2×
“[8] noted propulsive contractions in the colon of healthy volunteers with rapid rectal delivery of 1 mM CDCA.”
BackgroundBays, H. E., Goldberg, R. B., Truitt, K. E., & Jones, M. R. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.18.1975 · Cited by 212 · cited 1×
“Colesevelam improves glycemic and lipid parameters in patients with type 2 diabetes mellitus inadequately controlled with metformin-based therapy [33], and this effect may conceivably result from increased release of incretins such as glucagon-like peptide-1.”
BackgroundURSODEOXYCHOLIC ACID TREATMENT OF GALLSTONES
Maton, P. N., Murphy, G. M., & Dowling, R. H. (1977) · The Lancet · doi:10.1016/s0140-6736(77)90358-0 · Cited by 210
Ros, E., & Zambon, D. (1987) · Gut · doi:10.1136/gut.28.11.1500 · Cited by 198
Iser, J. H., Dowling, R. H., Mok, H. Y. I., & Bell, G. D. (1975) · New England Journal of Medicine · doi:10.1056/nejm197508212930804 · Cited by 192
Cremonini, F., Mullan, B. P., Camilleri, M., Burton, D. D., & Rank, M. R. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01344.x · Cited by 184 · cited 3×
“Gastrointestinal (GI) and colonic transit was conducted by a scintigraphic method [19] during the last 48 hours of drug ingestion.”
MethodSelf-citationCamilleri, M., Nadeau, A., Tremaine, W. J., Lamsam, J., Burton, D., Odunsi, S., Sweetser, S., & Singh, R. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01288.x · Cited by 153
Self-citationBile acids and colonic motility in the rabbit and the human.
Kirwan, W. O., Smith, A. N., Mitchell, W. D., Falconer, J. D., & Eastwood, M. A. (1975) · Gut · doi:10.1136/gut.16.11.894 · Cited by 153
Colonic absorption of unconjugated bile acids
Mekhjian, H. S., Phillips, S. F., & Hofmann, A. F. (1979) · Digestive Diseases and Sciences · doi:10.1007/bf01489324 · Cited by 138
Mok, H. Y. I., Bell, G. D., & Dowling, R. H. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91415-9 · Cited by 131 · cited 2×
“In studies of gallstone dissolution with exogenous chenodeoxycholic acid, diarrhea occurred in 40% of patients [13].”
BackgroundMethodSpiller, R. E., Brown, M. L., & Phillips, S. F. (1986) · Gastroenterology · doi:10.1016/0016-5085(86)90445-2 · Cited by 129 · cited 1×
“In humans, there is a relationship between the fecal bile acid excretion and colonic motility; however, this relationship is complicated by associated steatorrhea [9] since the delivery of fatty acids to the colon may also accelerate colonic transit [10].”
BackgroundCamilleri, M., Nadeau, A., Lamsam, J., Linker Nord, S., Ryks, M., Burton, D., Sweetser, S., Zinsmeister, A. R., & Singh, R. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01361.x · Cited by 125
Self-citationWingate, D. L., Phillips, S. F., & Hofmann, A. F. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107290 · Cited by 124 · cited 1×
“Conjugated and non-conjugated bile acids induce secretion in the human colon [3,4] by one or more mechanisms: activating intracellular secretory mechanisms (e.”
BackgroundViramontes, B. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02700-9 · Cited by 119 · cited 1×
“In these studies, we examined stool diaries [18], gastrointestinal transit [19–23], serum 7α-C4 [22], serum FGF-19, and colonic mucosal permeability [24].”
Bile acid stimulation of colonic adenylate cyclase and secretion in the rabbit
Conley, D. R., Coyne, M. J., Bonorris, G., Chung, A., & Schoenfield, L. J. (1976) · Digestive Diseases and Sciences · doi:10.1007/bf01072128 · Cited by 116 · cited 1×
“adenylate cyclase [5]), increasing mucosal permeability [6], and inhibiting apical Cl-/OH- exchange [7]).”
BackgroundBuchwald, H. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.11.1253 · Cited by 112
Sauter, G. H., Munzing, W., Ritter, C. V., & Paumgartner, G. (1999) · Digestive Diseases and Sciences · doi:10.1023/a:1026681512303 · Cited by 106 · cited 1×
“In these studies, we examined stool diaries [18], gastrointestinal transit [19–23], serum 7α-C4 [22], serum FGF-19, and colonic mucosal permeability [24].”
Accelerated Regional Bowel Transit and Overweight Shown in Idiopathic Bile Acid Malabsorption
Sadik, R., Abrahamsson, H., Ung, K.-A., & Stotzer, P.-O. (2004) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04139.x · Cited by 104 · cited 1×
“Idiopathic BAM was previously reported to be associated with accelerated small bowel and distal colonic transit [25].”
BackgroundBile Acid Malabsorption in Patients with Chronic Diarrhoea: Clinical Value of SeHCAT Test
S., W., Rasmussen, S. N., Madsen, J. L., & J., R. J. (2003) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520310004461 · Cited by 81 · cited 1×
“The prevalence of BAM in patients with IBS or chronic diarrhea may be as high as 33% [2], and up to 76% of patients with functional diarrhea or IBS-D with reduced bile acid retention on 75SeHCAT respond to bile acid binders [2,32].”
BackgroundBowel Habits and Bile Acid Malabsorption in The Months After Cholecystectomy
Sauter, G. H., Moussavian, A. C., Meyer, G., Steitz, H. O., Parhofer, K. G., & Jüngst, D. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05779.x · Cited by 81
Pathophysiology as a basis for understanding symptom complexes and therapeutic targets
Camilleri, M., & Talley, N. J. (2004) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2004.00516.x · Cited by 80 · cited 1×
“In these studies, we examined stool diaries [18], gastrointestinal transit [19–23], serum 7α-C4 [22], serum FGF-19, and colonic mucosal permeability [24].”
Self-citationHeaton, K. W., Parker, D., & Cripps, H. (1993) · Gut · doi:10.1136/gut.34.8.1108 · Cited by 76 · cited 1×
“Evidence of loss is not correlated with change in bowel function [28], and population-based studies show that, as a group, post-cholecystectomy patients do not have increased frequency or altered consistency of bowel movements [29].”
Hofmann, A. F., Loening‐Baucke, V., Lavine, J. E., Hagey, L. R., Steinbach, J. H., Packard, C. A., Griffin, T. L., & Chatfield, D. A. (2008) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31816920a6 · Cited by 75 · cited 1×
“Potential of Therapies Modulating Bile Salts Defective sulfation of CDC may cause functional constipation in children [34].”
BackgroundKeely, S. J., Scharl, M. M., Bertelsen, L. S., Hagey, L. R., Barrett, K. E., & Hofmann, A. F. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00076.2006 · Cited by 73 · cited 1×
“Chenodeoxycholate undergoes metabolism to lithocholate in the colon; however, the latter does not cause colonic secretion [26].”
BackgroundBile acids in the diarrhoea of ileal resection
Mitchell, W. D., Findlay, J. M., Prescott, R. J., Eastwood, M. A., & Horn, D. B. (1973) · Gut · doi:10.1136/gut.14.5.348 · Cited by 53 · cited 1×
“Bile acid concentration in stool of patients with ileal resection may reach 21mM chenodeoxycholate (CDC) [11].”
BackgroundTaurodeoxycholate modulates apical Cl-/OH- exchange activity in Caco2 cells
Alrefai, W. A., Saksena, S., Tyagi, S., Gill, R. K., Ramaswamy, K., & Dudeja, P. K. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9090-8 · Cited by 51
Taylor, I., Basu, P., Hammond, P., Darby, C., & Flynn, M. (1980) · Gut · doi:10.1136/gut.21.10.843 · Cited by 46 · cited 1×
“did not observe stimulation with 5 and 15 mM CDCA in the sigmoid colon of IBS patients [30]; whereas, Bampton et al.”
BackgroundRetrospective comparison of 'Cheno' and 'Urso' in the medical treatment of gallstones.
Meredith, T. J., Williams, G. V., Maton, P. N., Murphy, G. M., Saxton, H. M., & Dowling, R. H. (1982) · Gut · doi:10.1136/gut.23.5.382 · Cited by 43 · cited 1×
“Safety The literature on gallstone dissolution shows that 37% of patients treated with typical CDC doses of 14–15 mg per kg per day had effectively dissolved gallstones [35] and had hypertransaminasemia (within 3 times upper limit of normal) in the first 6 months of treatment [36].”
BackgroundTreatment of Constipation with Chenodeoxycholic Acid
Bazzoli, F., Malavolti, M., Petronelli, A., Barbara, L., & Roda, E. (1983) · Journal of International Medical Research · doi:10.1177/030006058301100211 · Cited by 37 · cited 2×
“25g per day CDC may improve stool frequency and consistency in some, but not all, constipated patients [31].”
BackgroundNa+-dependent bile acid transport in the ileum: The balance between diarrhea and constipation
van Tilburg, A. J. P., de Rooij, F. W. M., BLANKENSTEIN, M. V., van den Berg, J. W. O., & Bosman-Jacobs, E. P. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91286-f · Cited by 32 · cited 1×
“While earlier studies suggested up-regulation of the ileal active transporter [12] as a result of chronic loss of bile acids (which may reduce the bile acids reaching the colon), other data suggest increased delivery to the colon may occur if the ileal reabsorptive capacity for bile acids is exceeded.”
Result
Cited by
The Intestinal Microenvironment and Functional Gastrointestinal Disorders
Barbara, G., Feinle-Bisset, C., Ghoshal, U. C., Santos, J., Vanner, S. J., Vergnolle, N., Zoetendal, E. G., & Quigley, E. M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.028 · Cited by 335
“Alternate approaches include the measurement of fecal BAs, or serum levels of 7 a-hydroxy-4cholesten-3-one (C4), or a therapeutic trial of a bile salt sequestering agent.(34,41)”
BackgroundPeripheral mechanisms in irritable bowel syndrome
Camilleri, M. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1207068 · Cited by 300
Self-citationPeripheral Mechanisms in Irritable Bowel Syndrome
(2013) · New England Journal of Medicine · doi:10.1056/nejmc1214185 · Cited by 280
Duboc, H., Rainteau, D., Rajca, S., Humbert, L., Farabos, D., Maubert, M., Grondin, V., Jouet, P., Bouhassira, D., Seksik, P., et al. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01893.x · Cited by 256
Shin, A., Camilleri, M., Vijayvargiya, P., Busciglio, I., Burton, D., Ryks, M., Rhoten, D., Lueke, A., Saenger, A., Girtman, A., et al. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.04.020 · Cited by 192
“In patients with IBS-D, treatment with a BA sequestrant was associated with slower ascending colonic emptying and firmer stool.(4) Conversely, deficiency or sulfation of BAs may be associated with constipation.”
BackgroundSelf-citation
Metadata
- Authors
- Odunsi–Shiyanbade, S. T., Camilleri, M., McKinzie, S., Burton, D., Carlson, P., Busciglio, I. A., Lamsam, J., Singh, R., & Zinsmeister, A. R.
- Venue
- Clinical Gastroenterology and Hepatology
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 8
- Issue
- 2
- Pages
- 159-165.e5
- ISSN
- 1542-3565 (ISSN-L)
- OpenAlex
- W2040743397
- Cited by
- 182
- References
- 39
- FWCI
- 12.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.